STOCK TITAN

Venus Concept Inc. - VERO STOCK NEWS

Welcome to our dedicated page for Venus Concept news (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept stock.

Venus Concept Inc. (NASDAQ: VERO) is a pioneering leader in the global medical aesthetic market, offering advanced, minimally invasive, and non-invasive aesthetic and hair restoration technologies. The company stands out with its industry-first subscription model, designed to assist both emerging and established practices in achieving success in the competitive field of aesthetics.

Venus Concept's innovative business model provides aesthetic professionals with unparalleled benefits. These include the most comprehensive warranty program, robust marketing support, continuous clinical education, and valuable practice enhancement programs. This unique approach enables practitioners worldwide to leverage cutting-edge technologies and business solutions to elevate their services and improve the quality of life for their clients.

The company's product portfolio includes a range of advanced aesthetic systems such as Venus Versa™, Venus Legacy™, Venus Velocity™, Venus Viva™, Venus Freeze Plus™, and Venus Skin™. Additionally, Venus Concept provides innovative hair restoration systems like NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. These products address various medical aesthetic needs, including skin rejuvenation, body contouring, hair restoration, and cellulite reduction.

Headquartered in Toronto, Venus Concept operates in over 60 countries and maintains a direct presence in 12 markets, ensuring a global reach and local expertise. The company's latest advancements include the Venus Bliss MAX, a multifunctional platform offering diode laser applicators, Multi-Polar Radio Frequency, and Pulsed Electromagnetic Fields, all designed to treat a variety of aesthetic concerns.

Financially, Venus Concept continues to navigate its growth trajectory with strategic partnerships and investments. The company recently underwent significant debt restructuring, supported by Madryn Asset Management, which aims to enhance its financial stability and compliance with NASDAQ listing requirements. This support underscores a commitment to achieving sustainable profitability and operational efficiency.

Venus Concept's growth is also marked by its continuous expansion into new markets, such as Australia and Israel, where its products like the Venus Versa Pro and Venus Bliss MAX have been well received. These expansions are part of the company's broader strategy to extend its technological innovations to a global clientele, offering practitioners the tools they need to deliver exceptional aesthetic treatments.

Rhea-AI Summary
Venus Concept Inc. launches 'NEXThetics' series to enhance customer education and training, part of the 'Venus Aesthetic Intelligence' rebranding. The events aim to provide networking opportunities for aesthetics industry professionals to share ideas and success stories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.07%
Tags
none
-
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) completes a registered direct offering of 817,748 shares of common stock at $1.465 per share, along with unregistered warrants. The offering, led by H.C. Wainwright & Co., generates approximately $1.2 million in gross proceeds for general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.45%
Tags
-
Rhea-AI Summary
Venus Concept Inc. announces a registered direct offering of 817,748 shares of common stock at $1.465 per share, along with a concurrent private placement of unregistered warrants. The offering is priced at-the-market under Nasdaq rules.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.11%
Tags
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has received the CE Mark for Venus Versa Pro system in the European Union, following the US commercial launch. The system offers advanced skin resurfacing capabilities for various skin conditions. Dr. Hemanth Varghese highlighted the commitment to innovation and international markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52.46%
Tags
none
-
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) to release Q4 and fiscal year 2023 financial results on April 1, 2024. Conference call scheduled for discussion. Webcast available for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
-
Rhea-AI Summary
Venus Concept Inc. will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 13th – 14th. The Company's management will engage in virtual investor meetings, with no formal presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
conferences
Rhea-AI Summary
Venus Concept Inc. (VERO) is exploring strategic alternatives to maximize shareholder value, including financings, mergers, sales of assets, and more. The company has retained Canaccord Genuity LLC as its financial advisor for this process. There is no guarantee of any transaction, and no set timeline for completion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Venus Concept, Inc. announced the issuance of new secured convertible notes to EW Healthcare Partners, L.P. and one of its affiliates in an aggregate principal amount of $2.0 million. The notes have a maturity date of December 9, 2025, an annual interest rate of 90-day Adjusted SOFR + 8.5%, and are convertible into shares of common stock of the Company at an initial conversion price of $1.251 per share. This financing provides additional liquidity to support ongoing operations and execution of the Company's near-to-intermediate term strategic turnaround objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
News
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has announced the launch of Venus Prime, a structured in-house financing program for new customers in North America. The program offers competitive financing rates and payment flexibility for purchasing aesthetic medical devices, as well as a technology upgrade program. Venus Prime aims to support high-quality customers who may not qualify for traditional third-party financing due to current tight lending practices. This initiative, along with the company's focus on cash sales, is part of their effort to achieve cashflow breakeven.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
none
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has announced the expansion of its international distributor network with the signing of two new exclusive partnerships: Core Aesthetics Skin & Laser Limited in the United Kingdom and Spectra Medical Systems in India. The company aims to drive international growth through strong distributor partnerships, focusing on high-growth markets. Core Aesthetics brings years of industry experience and a reputation as a trusted distributor, while Spectra is a leading medical equipment distributor with extensive experience in the aesthetic industry. This expansion represents an important step for Venus Concept's strategic growth plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none

FAQ

What is the current stock price of Venus Concept (VERO)?

The current stock price of Venus Concept (VERO) is $0.36 as of December 24, 2024.

What is the market cap of Venus Concept (VERO)?

The market cap of Venus Concept (VERO) is approximately 2.6M.

What is Venus Concept Inc. known for?

Venus Concept Inc. is known for its advanced medical aesthetic devices and its unique subscription model that supports aesthetic practices worldwide.

What products does Venus Concept offer?

Venus Concept offers a range of aesthetic devices such as Venus Versa™, Venus Legacy™, Venus Velocity™, Venus Viva™, NeoGraft®, and the ARTAS iX® Robotic Hair Restoration system.

How does Venus Concept’s subscription model benefit practitioners?

The subscription model provides comprehensive warranties, marketing support, continuous education, and practice enhancement programs to help practitioners succeed.

In how many countries does Venus Concept operate?

Venus Concept operates in over 60 countries and maintains a direct presence in 12 markets.

What recent innovations has Venus Concept introduced?

Recent innovations include the Venus Versa Pro and Venus Bliss MAX, which offer advanced technologies for a variety of aesthetic treatments.

What financial steps has Venus Concept taken recently?

Venus Concept has undergone debt restructuring supported by Madryn Asset Management to enhance financial stability and compliance with NASDAQ requirements.

Where is Venus Concept headquartered?

Venus Concept is headquartered in Toronto, Canada.

What areas do Venus Concept’s devices target?

Venus Concept’s devices target skin rejuvenation, body contouring, cellulite reduction, and hair restoration.

Who are some of Venus Concept’s investors?

Venus Concept is backed by EW Healthcare Partners, HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

How does Venus Concept support its product users?

Venus Concept provides extensive support through warranties, marketing, continuous clinical education, and programs designed to enhance practice operations.

Venus Concept Inc.

Nasdaq:VERO

VERO Rankings

VERO Stock Data

2.61M
6.70M
6.08%
27.03%
19.95%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
TORONTO